Torna al Registre Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorSonneveld, Milan
dc.contributor.authorChiu, Shao-Ming
dc.contributor.authorBrakenhoff, Sylvia
dc.contributor.authorKaewdech, Apichat
dc.contributor.authorSeto, Wai-Kay
dc.contributor.authorButi Ferret, Maria
dc.contributor.authorPark, Jun Yong
dc.date.accessioned2023-08-17T11:16:15Z
dc.date.available2023-08-17T11:16:15Z
dc.date.issued2023-08
dc.identifier.citationSonneveld MJ, Chiu SM, Park JY, Brakenhoff SM, Kaewdech A, Seto WK, et al. Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-neegative chronic hepatitis B: A multicentre cohort study. JHEP Reports. 2023 Aug;5(8):100790.
dc.identifier.issn2589-5559
dc.identifier.urihttps://hdl.handle.net/11351/10092
dc.descriptionEntecavir; ADN del VHB; Tenofovir
dc.description.sponsorshipThe CREATE study was supported by Fujirebio. Materials for HBcrAg testing were provided free of charge to several participating centres. Fujirebio had no influence on CREATE study design, data collection, data analysis, writing of the current manuscript, or the decision to submit for publication.
dc.language.isoeng
dc.publisherElsevier
dc.relation.ispartofseriesJHEP Reports;5(8)
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectHepatitis B - Tractament
dc.subjectVirus de l'hepatitis B
dc.subjectMedicaments antivírics - Ús terapèutic
dc.subjectADN
dc.subject.meshHepatitis B, Chronic
dc.subject.meshDNA, Viral
dc.subject.meshAntiviral Agents
dc.titleLower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-neegative chronic hepatitis B: A multicentre cohort study
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1016/j.jhepr.2023.100790
dc.subject.decshepatitis B crónica
dc.subject.decsADN vírico
dc.subject.decsantivíricos
dc.relation.publishversionhttps://doi.org/10.1016/j.jhepr.2023.100790
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Sonneveld MJ, Brakenhoff SM] Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, the Netherlands. [Chiu SM] Department of Internal Medicine, Koahsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan. [Park JY] Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea. [Kaewdech A] Faculty of Medicine, Prince of Songkla University, Hatyai, Thailand. [Seto WK] Department of Medicine, State Key Laboratory for Liver Research, The University of Hong Kong, Hong Kong. [Buti M] Unitat del Fetge, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Ciberehd del Intituto Carlos III de Barcelona, Spain
dc.identifier.pmid37484211
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Fitxers en aquest element

Thumbnail
Thumbnail

Aquest element apareix en la col·lecció o col·leccions següent(s)

Torna al Registre Simple